TN1298 |
6''-O-Acetylglycitin
|
134859-96-4
|
98%
|
|
6''-O-Acetylglycitin is a potential nutriceutical, it is also a potent LDH inhibitor.
|
T13100 |
TC HSD 21
|
330203-01-5
|
98%
|
|
TC HSD 21 is a potent and highly selective inhibitor of 17β-hydroxysteroid dehydrogenase type 3 (IC50 = 14 nM).
|
T2637 |
ADH-1
|
229971-81-7
|
98%
|
|
Exherin (ADH-1) is an N-cadherin antagonist, inhibits N-cadherin mediated cell adhesion with potential antineoplastic and antiangiogenic activities.
|
T13453 |
CGRP antagonist 1
|
1123757-49-2
|
98%
|
|
CGRP antagonist 1 is a highly potent antagonist of CGRP receptor(Ki and IC50 of 35 and 57 nM, respectively).
|
T11611 |
IDH1 Inhibitor 2
|
2244895-42-7
|
98%
|
|
IDH1 Inhibitor 2 (compound 13) is a potent IDH1 inhibitor via direct covalent modification of His315 (IC50: 110 nM).
|
T10160 |
11β-HSD1-IN-1
|
1203956-47-1
|
98%
|
|
11β-HSD1-IN-1 is an inhibitor of 11β-hydroxydehydrogenase 1 (11β-HSD1, IC50: 52 nM), and used for the treatment of pain.
|
T14780 |
BRD9185
|
2057420-29-6
|
98%
|
|
BRD9185 is an inhibitor of Dihydroorotate dehydrogenase (DHODH) with an EC50 of 16 nM against multidrug-resistant blood-stage parasites in vitro.
|
T14383 |
AZD8329
|
1048668-70-7
|
98%
|
|
AZD8329 is a potent inhibitor of 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1)(IC50 of 9 nM for human 11β-HSD1), and displays excellent selectivity versus 1...
|
T12663 |
(Rac)-BMS-816336
|
T12663
|
98%
|
|
(Rac)-BMS-816336 (Compound 6n) is a racemate of BMS-816336. (Rac)-BMS-816336 is a potent inhibitor of human and mouse 11β-hydroxysteroid dehydrogenase type 1 (11...
|
T13054 |
T-3764518
|
1809151-56-1
|
98%
|
|
T-3764518 is a novel and potent inhibitor of stearoyl coenzyme A desaturase (SCD)(IC50 of 4.7 nM).
|
T12614L |
BMS-816336
|
1009583-20-3
|
98%
|
|
BMS-816336 is a novel, orally bioavailable inhibitor, and potent against human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme with an IC50 of 3.0 nM[1...
|
T27214 |
DSM421
|
2011769-21-2
|
98%
|
|
DSM421 is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against ...
|
T67875 |
DHODH-IN-23
|
1346705-53-0
|
98%
|
|
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research.
|
T11238 |
Etamicastat
|
760173-05-5
|
98%
|
|
Etamicastat can be used in the research of cardiovascular diseases. Etamicastat (BIA 5-453) is a potent and reversible dopamine-β-hydroxylase (DBH) inhibitor wit...
|
T25209 |
CB29
|
315239-63-5
|
98%
|
|
CB29 is a specific inhibitor of aldehyde dehydrogenase 3A1 (ALDH3A1).
|
T11238L |
Etamicastat hydrochloride
|
677773-32-9
|
98%
|
|
Etamicastat hydrochloride is a peripherally selective dopamine beta-hydroxylase inhibitor that reduces hypertension.
|
T15362 |
FX-11
|
213971-34-7
|
98%
|
|
FX-11 is A potent, selective and competitive specific inhibitor of lactate dehydrogenase A (LDHA) with a Ki of 8 μM. FX-11 can activate PKM2 (pyruvate kinase M2)...
|
T67903 |
1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine
|
946394-50-9
|
98%
|
|
1-(biphenyl-4-ylsulfonyl)-4-[3-(trifluoromethyl)pyridin-2-yl]piperazine is an inhibitor of 11β-hydroxysteroid dehydrogenase (11β-HSD1).
|
T11023 |
DHODH-IN-14
|
1364791-93-4
|
98%
|
|
DHODH-IN-14 is an analog of hydroxyfuran pyrimidine A771726. DHODH-IN-14 is a dihydroorotate dehydrogenase (DHODH) inhibitor IC50 0.49 μM mouse liver DHODH. DHOD...
|
T38163 |
ML-148
|
451496-96-1
|
98%
|
|
ML-148 is a selective inhibitor of 15-hydroxy prostaglandin dehydrogenase (15-PGDH, IC50 = 56 nM). ML-148 can be used to profile across a panel of related dehydr...
|